The Immune Response and Its Therapeutic Modulation in Bronchiectasis

Bronchiectasis (BC) is a chronic pulmonary disease with tremendous morbidity and significant mortality. As pathogen infection has been advocated as a triggering insult in the development of BC, a central role for the immune response in this process seems obvious. Inflammatory cells are present in bo...

Full description

Saved in:
Bibliographic Details
Main Authors: Massoud Daheshia, James D. Prahl, Jacob J. Carmichael, John S. Parrish, Gilbert Seda
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Pulmonary Medicine
Online Access:http://dx.doi.org/10.1155/2012/280528
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832556525360513024
author Massoud Daheshia
James D. Prahl
Jacob J. Carmichael
John S. Parrish
Gilbert Seda
author_facet Massoud Daheshia
James D. Prahl
Jacob J. Carmichael
John S. Parrish
Gilbert Seda
author_sort Massoud Daheshia
collection DOAJ
description Bronchiectasis (BC) is a chronic pulmonary disease with tremendous morbidity and significant mortality. As pathogen infection has been advocated as a triggering insult in the development of BC, a central role for the immune response in this process seems obvious. Inflammatory cells are present in both the airways as well as the lung parenchyma, and multiple mediators of immune cells including proteases and cytokines or their humoral products are increased locally or in the periphery. Interestingly, a defect in the immune system or suppression of immune response during conditions such as immunodeficiency may well predispose one to the devastating effects of BC. Thus, the outcome of an active immune response as detrimental or protective in the pathogenesis of BC may be dependent on the state of the patient's immunity, the severity of infection, and the magnitude of immune response. Here we reassess the function of the innate and acquired immunity in BC, the major sites of immune response, and the nature of the bioactive mediators. Furthermore, the potential link(s) between an ongoing immune response and structural alterations accompanying the disease and the success of therapies that can modulate the nature and extent of immune response in BC are elaborated upon.
format Article
id doaj-art-c624325e2978466f971535d9784a831d
institution Kabale University
issn 2090-1836
2090-1844
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Pulmonary Medicine
spelling doaj-art-c624325e2978466f971535d9784a831d2025-02-03T05:45:10ZengWileyPulmonary Medicine2090-18362090-18442012-01-01201210.1155/2012/280528280528The Immune Response and Its Therapeutic Modulation in BronchiectasisMassoud Daheshia0James D. Prahl1Jacob J. Carmichael2John S. Parrish3Gilbert Seda4Department of Pulmonary Medicine, Naval Medical Center San Diego, San Diego, CA 92134, USADepartment of Pulmonary Medicine, Naval Medical Center San Diego, San Diego, CA 92134, USADepartment of Pulmonary Medicine, Naval Medical Center San Diego, San Diego, CA 92134, USADepartment of Pulmonary Medicine, Naval Medical Center San Diego, San Diego, CA 92134, USADepartment of Pulmonary Medicine, Naval Medical Center San Diego, San Diego, CA 92134, USABronchiectasis (BC) is a chronic pulmonary disease with tremendous morbidity and significant mortality. As pathogen infection has been advocated as a triggering insult in the development of BC, a central role for the immune response in this process seems obvious. Inflammatory cells are present in both the airways as well as the lung parenchyma, and multiple mediators of immune cells including proteases and cytokines or their humoral products are increased locally or in the periphery. Interestingly, a defect in the immune system or suppression of immune response during conditions such as immunodeficiency may well predispose one to the devastating effects of BC. Thus, the outcome of an active immune response as detrimental or protective in the pathogenesis of BC may be dependent on the state of the patient's immunity, the severity of infection, and the magnitude of immune response. Here we reassess the function of the innate and acquired immunity in BC, the major sites of immune response, and the nature of the bioactive mediators. Furthermore, the potential link(s) between an ongoing immune response and structural alterations accompanying the disease and the success of therapies that can modulate the nature and extent of immune response in BC are elaborated upon.http://dx.doi.org/10.1155/2012/280528
spellingShingle Massoud Daheshia
James D. Prahl
Jacob J. Carmichael
John S. Parrish
Gilbert Seda
The Immune Response and Its Therapeutic Modulation in Bronchiectasis
Pulmonary Medicine
title The Immune Response and Its Therapeutic Modulation in Bronchiectasis
title_full The Immune Response and Its Therapeutic Modulation in Bronchiectasis
title_fullStr The Immune Response and Its Therapeutic Modulation in Bronchiectasis
title_full_unstemmed The Immune Response and Its Therapeutic Modulation in Bronchiectasis
title_short The Immune Response and Its Therapeutic Modulation in Bronchiectasis
title_sort immune response and its therapeutic modulation in bronchiectasis
url http://dx.doi.org/10.1155/2012/280528
work_keys_str_mv AT massouddaheshia theimmuneresponseanditstherapeuticmodulationinbronchiectasis
AT jamesdprahl theimmuneresponseanditstherapeuticmodulationinbronchiectasis
AT jacobjcarmichael theimmuneresponseanditstherapeuticmodulationinbronchiectasis
AT johnsparrish theimmuneresponseanditstherapeuticmodulationinbronchiectasis
AT gilbertseda theimmuneresponseanditstherapeuticmodulationinbronchiectasis
AT massouddaheshia immuneresponseanditstherapeuticmodulationinbronchiectasis
AT jamesdprahl immuneresponseanditstherapeuticmodulationinbronchiectasis
AT jacobjcarmichael immuneresponseanditstherapeuticmodulationinbronchiectasis
AT johnsparrish immuneresponseanditstherapeuticmodulationinbronchiectasis
AT gilbertseda immuneresponseanditstherapeuticmodulationinbronchiectasis